Cargando…
Development and validation of a novel 15‐CpG‐based signature for predicting prognosis in triple‐negative breast cancer
DNA methylation is an important biological regulatory mechanism that changes gene expression without altering the DNA sequence. Increasing studies have revealed that DNA methylation data play a vital role in the field of oncology. However, the methylation site signature in triple‐negative breast can...
Autores principales: | Peng, Yang, Shui, Lin, Xie, Jian, Liu, Shengchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417707/ https://www.ncbi.nlm.nih.gov/pubmed/32649035 http://dx.doi.org/10.1111/jcmm.15588 |
Ejemplares similares
-
CimpleG: finding simple CpG methylation signatures
por: Maié, Tiago, et al.
Publicado: (2023) -
14-CpG-Based Signature Improves the Prognosis Prediction of Hepatocellular Carcinoma Patients
por: Jiang, Hong-ye, et al.
Publicado: (2020) -
Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016) -
Tumor Microenvironment Multiple Responsive Nanoparticles for Targeted Delivery of Doxorubicin and CpG Against Triple-Negative Breast Cancer
por: Gu, Fenfen, et al.
Publicado: (2022) -
Suppressive CpG
por: Van Epps, Heather L.
Publicado: (2005)